Detalhe da pesquisa
1.
Quality of endoscopic surveillance of Barrett's esophagus.
Scand J Gastroenterol
; 53(3): 256-259, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29361878
2.
Promoter hypermethylation in plasma-derived cell-free DNA as a prognostic marker for pancreatic adenocarcinoma staging.
Int J Cancer
; 141(12): 2489-2497, 2017 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28857158
3.
A nationwide retrospective study of perioperative chemotherapy for gastroesophageal adenocarcinoma: tolerability, outcome, and prognostic factors.
Ann Surg Oncol
; 22(5): 1540-7, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25348777
4.
Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with localized pancreatic ductal adenocarcinoma.
Front Oncol
; 13: 1211292, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37333823
5.
National clinical practice guidelines for the treatment of symptomatic gallstone disease: 2021 recommendations from the Danish Surgical Society.
Scand J Surg
; 111(3): 11-30, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36000716
6.
Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic Adenocarcinoma.
Cancers (Basel)
; 13(22)2021 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830873
7.
Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma.
Oncotarget
; 8(55): 93942-93956, 2017 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29212200
8.
Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma.
Clin Epigenetics
; 8: 117, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27891190
9.
Treatment-related frequency of venous thrombosis in lower esophageal, gastro-esophageal and gastric cancer--a clinical prospective study of outcome and prognostic factors.
Thromb Res
; 135(5): 802-8, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25743885